Clinical Trial: Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Observational

Official Title: Long-term Quality of Life Symptom Burden in Acute Promyelocytic Leukemia (APL) Patients Treated With Arsenic Trioxide (ATO) or Standard Chemotherapy

Brief Summary: This is a prospective and international observational study run by the GIMEMA. All data will be centrally collected and analyzed at the GIMEMA Data Center in Rome (Italy). Patients reported outcomes will be collected using internationally validated questionnaires.

Detailed Summary:
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto

Current Primary Outcome: Number of cross-sectional differences in fatigue severity [ Time Frame: Two years after study entry. ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Gruppo Italiano Malattie EMatologiche dell'Adulto

Dates:
Date Received: January 24, 2017
Date Started: April 2017
Date Completion: February 2019
Last Updated: March 29, 2017
Last Verified: March 2017